Upon launch, Jean-Louis Guillaud and the head of ORTF, Arthur Conte, went on the air and together laid out a vision of the new service. The station's first President Director General (PDG), Jean-Louis Guillaud, decided to call on the ORTF's regional television services and aspiring young staff to join the new network, which would broadcast in colour, with no advertising or continuity announcers (although out-of-vision announcers were later introduced). La Troisième Chaîne Couleur began broadcasting at 7:00pm CET on 30 April 1972. Prior to the establishment of RFO, now Outre-Mer 1ère, it also broadcast to the various French overseas departments and territories. The channel was known as France Régions 3 ( FR3) until its official replacement by France 3 in September 1992. The channel also broadcasts various national programming and national and international news from Paris.
It is made up of a network of regional television services providing daily news programming and around ten hours of entertainment and cultural programming produced for and about the regions each week. For more guidance, see Wikipedia:Translation.įrance 3 ( pronounced ) is a French free-to-air public television channel and part of the France Télévisions group, which also includes France 2, France 4, and France 5.You should also add the template to the talk page.A model attribution edit summary is Content in this edit is translated from the existing French Wikipedia article at ] see its history for attribution. You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation.If possible, verify the text with references provided in the foreign-language article. Do not translate text that appears unreliable or low-quality.Consider adding a topic to this template: there are already 4,960 articles in the main category, and specifying |topic= will aid in categorization.Machine translation like DeepL or Google Translate is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.Another method proposed for measuring androgenization of hairs is to determine the fraction of vellus (unmedullated) hairs in a sample of 100 shaved hairs, defined as the 'vellus index' (Madanes and Novotny, 1987). the number of hairs per defined surface area) either by direct counting (Peereboom-Wynia, 1972) or by photography (Hines et al., 2001) measuring the rate of hair growth using calibrated glass capillary tubes (Jones et al., 1981 Barth, 1997) or photography ( Holdaway et al., 1985 Hines et al., 2001) (requiring that patients shave at predetermined intervals of time before the measurement). 1991 Barth, 1997) determining the density of terminal hairs (i.e. These include weighing the hairs obtained by dry shaving the body region of interest (demanding a high degree of cooperation by the patient and precise weighing methods) (Casey et al., 1966) measuring the outer diameter of either plucked or clipped hairs (Cumming et al., 1982 Barth et al., 1989 O'Brien, et al. More objective methods of assessing hair growth are available.
The evidence that high-dose cyproterone acetate results in no additional benefit on hirsutism compared with low-dose cyproterone acetate is based on only 1 study 63 with relatively small numbers, and it was suggested that the effect of larger doses may become apparent in expanded studies.
The role of peripheral receptor blockade is underlined by the decrease in the hirsutism score with flutamide 10,20,25,40 and spironolactone 1,40,57 only, which are receptor antagonists without gonadotropin suppressive effect, and by the lesser effect of ethinylestradiol and low-dose cyproterone acetate (42 mg cyproterone acetate/ cycle) 34,54,60 compared with ethinylestradiol and high-dose cyproterone acetate (550-1100 mg cyproterone acetate/cycle) in the present and previous studies, 24,57 despite similar gonadotropin suppression. The antiandrogenic efficacy of ethinylestradiol and high-dose cyproterone acetate in the present study results from both hormone suppression (gonadotropins and, subsequently, ovarian androgens) and androgen receptor blockade by cyproterone acetate.
0 kommentar(er)
